NEPT - Neptune Wellness Solutions Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.8000
-0.2400 (-5.94%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close4.0400
Open4.0600
Bid0.0000 x 3200
Ask0.0000 x 3000
Day's Range3.7600 - 4.0600
52 Week Range2.4200 - 6.5700
Volume1,259,483
Avg. Volume1,142,351
Market Cap354.283M
Beta (3Y Monthly)2.66
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2008-07-24
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga

    14 Top Cannabis Stocks Targeted By Short Sellers

    After a weak couple of months, cannabis stocks rallied in the first week of September . That rally seems to have stalled so far in the second week of the month. S3 Partners analyst Ihor Dusaniwsy said ...

  • Neptune Wellness Solutions: Buy the Dip?
    Motley Fool

    Neptune Wellness Solutions: Buy the Dip?

    The business might yet prove to be a less risky play on the rise of cannabis, but it has plenty left to prove to investors.

  • An In-Depth Breakdown of Derivative Cannabis Sales in the U.S.
    Motley Fool

    An In-Depth Breakdown of Derivative Cannabis Sales in the U.S.

    An investment bank research report projects where every marijuana dollar spent will wind up in a mature U.S. market.

  • Market Exclusive

    Neptune Hires Cannabis Sommelier and VP of Operations

    Neptune Wellness Solutions (NASDAQ: NEPT) (TSX: NEPT) has named two new additions to its team to support the company's rapid growth. The company has appointed Stephen Lijoi as vice president operations and José Dominguez as cannabis sommelier and formulation specialist. Lijoi will oversee all of Neptune's extraction, manufacturing and packaging operations at the company's two facilities, […]The post Neptune Hires Cannabis Sommelier and VP of Operations appeared first on Market Exclusive.

  • 3 of the Most De-Risked Cannabis Stocks
    Motley Fool

    3 of the Most De-Risked Cannabis Stocks

    Existing supply deals or contracts make these pot stocks far less risky than many of their peers.

  • Neptune Technologies (NEPT) Reports Q1 Loss, Misses Revenue Estimates
    Zacks

    Neptune Technologies (NEPT) Reports Q1 Loss, Misses Revenue Estimates

    Neptune Tech (NEPT) delivered earnings and revenue surprises of -100.00% and -27.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    3 Pot Stocks With Rising Profit Projections

    Although most cannabis stock earnings estimates are falling, these companies are bucking the trend.

  • Neptune Technologies (NEPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks

    Neptune Technologies (NEPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Only These 9 Cannabis Stocks Rose in July
    Motley Fool

    Only These 9 Cannabis Stocks Rose in July

    While these nine pot stocks rose, 38 others ended lower by at least 10%.

  • 3 Best Cannabis Stocks of July -- Are They Buys Now?
    Motley Fool

    3 Best Cannabis Stocks of July -- Are They Buys Now?

    Most cannabis stocks performed dismally last month. But not these three.

  • Benzinga

    Neptune Wellness Enters US Cannabis Market Through Sugarleaf Acquisition

    Cannabinoid extraction and purification company Neptune Wellness Solutions (NASDAQ: NEPT ) has acquired Sugarleaf, a cannabis supplier in North Carolina. As a Canadian-based, licensed producer of cannabis ...

  • Short-Term Outlook for Neptune Wellness Solutions (NEPT) Looks Challenging
    TipRanks

    Short-Term Outlook for Neptune Wellness Solutions (NEPT) Looks Challenging

    Neptune Wellness Solutions (NEPT) has been on a tear lately, soaring nearly 40% since July 9 to trade at $6.14 per share as I write. Taking into account the catalysts driving the share price, it suggests a strong growth narrative over the long term.While that's true, there's something the market is neglecting because of the positive outlook investors have for Neptune at this time, and that is in the short term, it will be challenged by cash limitations if it isn't able to generate revenue in the near future.Recent private placement of common stock and expansionA recent catalyst was the announcement by the company it had completed a private placement of common stock that brought the company another $41.4 million in capital. That has helped alleviate concerns over the small $9.8 million in cash on hand the company had at the end of March.Proceeds will be used in part to fund the $18 million acquisition of SugarLeaf Labs and Forest Remedies LLC. Terms of that deal were $12 million in cash and the $6 million in common stock. The remainder will be used for working capital and general corporate purposes.The addition of SugarLeaf will help boost its extraction capacity from 200 metric tons to 1,500 metric tons. This follows up on the announcement a couple of weeks ago that Health Canada approved of permits for adding an expansion room using cold ethanol extraction. That is expected to increase input capacity for Neptune from 30,000 kilograms to 200,000 kilograms.The company also received an amendment from Health Canada that allows it to expand an encapsulation room. That increases production capacity of cannabis oil capsules that use Licaps tech that the company has licensed from Lonza Group AG.Neptune will have capacity to produce as much as 200 million capsules yearly.The company has already started the process of bring commercial operations on line in the second fiscal quarter. This is important because the company could become squeezed in the short term even with the successful common stock placement.Short-term challengesEven though Neptune has been attracting a lot of investor interest, the reality is it has sold very little in the way of cannabis products. In the last reporting period it only sold $12,000 worth of cannabis extracts; the first time it competed in that market.In the immediate future, the company guided for less than $1 million in sales for the cannabis segment in the first fiscal quarter of 2020. Part of that comes from the inept Health Canada that has been slow in approving licenses in general. The license Neptune is waiting for will cover all of its existing extraction capacity of 200 metric tons.The good news is the company has sold out of existing capacity for fiscal 2020 and fiscal 2021. Expansion and acquiring Sugarleaf were the key way the company has chosen to reduce the short-term challenges associated with low sales.For that reason, even with the additional capital, if it isn't able to grow sales significantly in the near term, it will struggle to perform in accordance with growing expectations. There's also the uncertainty surrounding Health Canada and how long it'll take in the approval process. That could mean the company may not be able to utilize the added capacity until some time in 2020.With a net loss of $12 million in the last reporting period, it won't take long for Neptune to burn through the $41.4 million. It definitely needs to start generating more cannabis revenue before it becomes an albatross around its neck.ConclusionOver the long term Neptune Wellness Solutions has a lot of potential. But perhaps more than many of its competitors, it has short-term cash challenges that could rapidly become a major headwind if it can't find ways to generate more revenue from cannabis.With its wholly owned subsidiary, 9354-7537 Quebec Inc. now being granted its license amendments from Health Canada, which boosts its extraction capacity to 200,000 kilograms, the long-term prognosis for Neptune looks good.As with a number of its peers, it must find answers to short-term capital requirements as the growth process appears that it'll take longer than expected because of matters outside of its control, by which I mean a slow-moving Health Canada.As for matters within its control, it does need to ramp up extraction capacity in the near term in order to meet the requirements of its customers, which are ready to buy up its capacity over the next couple of years.Once the stock takes a breather, I believe investors are going to start looking closer at its short-term prospects and how its going to handle the sales challenges as it continues to burn cash.The share price will probably take a hit once it's understood the value of the stock will remained locked in for some time.See NEPT's price targets and analyst ratings on TipRanks

  • Why British American Tobacco, Neptune Wellness Solutions, and Union Pacific Jumped Today
    Motley Fool

    Why British American Tobacco, Neptune Wellness Solutions, and Union Pacific Jumped Today

    Despite a turbulent broader market, good news lifted these shares.

  • Here's Why Neptune Wellness Solutions Rose as Much as 20.7% Today
    Motley Fool

    Here's Why Neptune Wellness Solutions Rose as Much as 20.7% Today

    The business announced a private placement to pad its balance sheet ahead of a major expansion.

  • Benzinga

    Neptune Wellness Says $41.4M Private Placement Will Help Finance M&A Deals

    Cannabis company Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) said Thursday it has completed a private placement delivering gross proceeds to the company of $41.4 million. Both existing and new institutional investors participated, led by Perceptive Advisors. Upon closing, Neptune issued a total of 9.42 million common shares with a purchase price of $4.40 per share.

  • Market Exclusive

    Cannabis Stock News Daily Roundup July 9

    Wellness and CBD brand Kaleidoscope Labs has raised a $4 million seed round support their expansion efforts. New York-based venture capital firm RRE Ventures led the round with participation from Barry Rosenstein, founder of JANA Partners. SOL Global Investments (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) has completed a $50 million private placement financing by way of the […]The post Cannabis Stock News Daily Roundup July 9 appeared first on Market Exclusive.

  • MarketWatch

    Neptune Wellness CEO Jim Hamilton steps down, succeeded by Michael Cammarata

    Neptune Wellness Solutions Inc. said Monday Chief Executive Jim Hamilton has stepped down after more than 4 years in the role, but will remain with the cannabis extraction company as an advisor. Neptune named Micheal Cammarata as its new CEO, effective Monday. The company said Cammarata, who has been a "serial entrepreneur" over the past 20 years, is the co-founder of wellness brand Schmidt's Naturals, which is now a business unit of Unilever PLC . "[Cammarata] has identified new trends and opportunities which led to the development of market-leading products," said Chairman John Moretz. "These critical skills should benefit our customers. Moreover, Michael possesses the right mix of operational CEO experience, leadership skills, and technology industry expertise to help elevate Neptune to the next level." Neptune's stock, which was still inactive in premarket trading, has soared 74.4% year to date, while the ETFMG Alternative Harvest ETF has rallied 27.3% and the Dow Jones Industrial Average has gained 15.4%.

  • Why Canopy Growth Partner Neptune Wellness' Stock Soared 71% in the First Half of 2019
    Motley Fool

    Why Canopy Growth Partner Neptune Wellness' Stock Soared 71% in the First Half of 2019

    This marijuana stock continues extracting more money from investors thanks to 2019 extraction deals with Tilray and The Green Organic Dutchman.

  • Motley Fool

    These Are the Only 15 Pot Stocks That Rose in the Second Quarter

    Only around 1 in 4 marijuana stocks ended the second quarter higher.

  • 5 Best Cannabis Stocks of 2019 So Far -- Are They Buys Now?
    Motley Fool

    5 Best Cannabis Stocks of 2019 So Far -- Are They Buys Now?

    These cannabis stocks racked up gains of at least 60% in the first half of 2019. Which ones are most likely to keep the momentum going?

  • Why Medicare for all could 'dramatically' increase access to medical marijuana
    Yahoo Finance

    Why Medicare for all could 'dramatically' increase access to medical marijuana

    Medicare for all may not be just a Democratic talking point as the 2020 campaign kicks into high gear. It could also “dramatically” increase access to medical marijuana, according to Nicholas Vita, CEO of cannabis company Columbia Care.

  • The Sneaky Way to Play the CBD Craze: Extraction
    Motley Fool

    The Sneaky Way to Play the CBD Craze: Extraction

    Extraction-service providers may offer predictability that's hard to come by in the cannabis industry.

  • Benzinga

    The Secret Sauce Behind The Best Performing Cannabis ETF In Canada

    Some of those may have gained their wealth through the Evolve Marijuana ETF (TSE:SEED) (OTC: EVVLF), which, in the last year, has delivered the best performance among all cannabis ETFs. Need more cannabis news? Evolve launched SEED on the Toronto Stock Exchange roughly 14 months ago.

  • Market Exclusive

    Neptune Gets Approval for Expansion of Cannabis Oil Capsule Production

    Neptune Wellness Solutions (NASDAQ: NEPT) (TSX: NEPT) has reported that its subsidiary 9354-7537 Québec has received approval from Health Canada for its cannabis operations. Extraction Capacity Increases to 200,000 kg The scope of the amendment received from Health Canada permits expansion of cannabis operation areas to include an additional extraction room where Neptune will perform cold […]The post Neptune Gets Approval for Expansion of Cannabis Oil Capsule Production appeared first on Market Exclusive.

  • Company News For Jun 13, 2019
    Zacks

    Company News For Jun 13, 2019

    Companies in the news are: PLAY, NEPT, TGODF, RGS, GOOGL and HEB